# Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus

> **NCT06222853** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 22 (actual)

## Conditions studied

- Systemic Lupus Erythematosus
- CAR-T Cell Therapy

## Interventions

- **BIOLOGICAL:** anti-CD19-CAR-T cells

## Key facts

- **NCT ID:** NCT06222853
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-10
- **Primary completion:** 2025-04-04
- **Final completion:** 2026-12-30
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06222853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06222853, "Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06222853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*